Skip to main content
. Author manuscript; available in PMC: 2023 Jun 8.
Published in final edited form as: J Med Genet. 2022 Jul 11;60(3):241–246. doi: 10.1136/jmg-2022-108733

Table 2.

Prophylactic Total Gastrectomy Decision Making Survey Results

PTGneg
(N=44)
PTGpos
(N=76)
Age at CDH1 diagnosis, median (range) 54 (17-72) 45 (20-66) P=0.089
Time to decision, median months (range) 27 (8-71) 8 (1-60) P<0.001
  <12 months, N (%) 7 (15.9) 46 (60.5) P<0.001
  ≥12 months, N (%) 37 (84.1) 30 (39.5)
Decision for TG
  Family history, N (%) 16 (36.4) 54 (71.1) P<0.001
  EGD results, N (%) 13 (29.5) 13 (17.1) P=0.111
  Doctor’s Recommendation, N (%) 0 (0.0) 13 (17.1) n/a
  More information, N (%) 9 (20.5) 0 (0.0) n/a
  Other, N (%) 0 (0.0) 0 (0.0) n/a
Concerns/Values Included P=0.021
  Yes, N (%) 41 (93.2) 76 (100.0)
  No, N (%) 3 (6.8) 0 (0.0)
Relative s/p PTG, N (%) 33 (75.0) 59 (77.6) P=0.743
Family Death to GC
  No, N (%) 21 (47.7) 13 (17.1) P<0.001
  Yes, N (%) 23 (52.3) 63 (82.9)
    1st or 2nd degree relative, N (%) 19 (43.2) 51 (67.1) P=0.010
    Multiple Relatives, N (%) 11 (25.0) 22 (28.9) P=0.641

PTG, prophylactic total gastrectomy; GC, gastric cancer.